Whole-exome sequencing reanalysis at 12 months boosts diagnosis and is cost-effective when applied early in Mendelian disordersLisa Ewans, Tony Roscioli, Deborah Schofield et al.|Genetics in Medicine|2018Cited by 200
Whole exome and genome sequencing in mendelian disorders: a diagnostic and health economic analysisLisa Ewans, Tony Roscioli, Carey‐Anne Evans et al.|European Journal of Human Genetics|2022Cited by 123
Integrating exome sequencing into a diagnostic pathway for epileptic encephalopathy: Evidence of clinical utility and cost effectivenessElizabeth E. Palmer, Rani Sachdev, Deborah Schofield et al.|Molecular Genetics & Genomic Medicine|2018Cited by 115
Cell and Molecular Determinants of <i>In Vivo</i> Efficacy of the BH3 Mimetic ABT-263 against Pediatric Acute Lymphoblastic Leukemia XenograftsSanti Suryani, Richard B. Lock, Hernán Carol et al.|Clinical Cancer Research|2014Cited by 84
Childhood acute myeloid leukemia shows a high level of germline predispositionSaumya E. Samaraweera, Richard J. D’Andrea, Paul Wang et al.|Blood|2021Cited by 13